Search results
Guggenheim sets target on Rubrik shares, citing growth potential By Investing.com
Investing.com· 5 days agoOn Monday, Guggenheim initiated coverage on Rubrik Inc (NYSE: RBRK) with a Buy rating and a price...
The Dodgers Mogul and the Indian Infrastructure Giant That Wasn’t
Bloomberg· 2 days agoMuch of the firm’s success—and Walter’s estimated $6 billion wealth—derives from buying sleepy...
TTEC Holdings, Inc. (NASDAQ:TTEC) Shares Bought by Aigen Investment Management LP
ETF DAILY NEWS· 14 hours agoAigen Investment Management LP grew its holdings in TTEC Holdings, Inc. (NASDAQ:TTEC – Free Report)...
CureVac (NASDAQ:CVAC) Sees Large Volume Increase
ETF DAILY NEWS· 16 hours agoShares of CureVac (NASDAQ:CVAC – Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 290,327 shares traded hands during mid-day trading, a decline of 63% from the ...
enGene (NASDAQ:ENGN) Stock Price Down 5.7%
ETF DAILY NEWS· 16 hours agoenGene Holdings Inc. (NASDAQ:ENGN – Get Free Report)’s share price fell 5.7% during mid-day trading on Wednesday . The stock traded as low as $12.52 and last traded at $12.52. 821 shares changed ...
A tax vote incoming
Politico· 4 days agoRosa DeLauro (D-Conn.), the ranking member on the House Appropriations Committee. WELCOME TO THE FIRM: Former House Ways and Means Chair Kevin Brady seemed to have a pretty ...
AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
ETF DAILY NEWS· 6 days agoCantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald’s price objective ...
Zacks Research Equities Analysts Raise Earnings Estimates for CenterPoint Energy, Inc. (NYSE:CNP)
ETF DAILY NEWS· 3 days agoCenterPoint Energy, Inc. (NYSE:CNP – Free Report) – Investment analysts at Zacks Research lifted...
Wedbush Analysts Raise Earnings Estimates for Immunome, Inc. (NASDAQ:IMNM)
ETF DAILY NEWS· 6 days agoImmunome, Inc. (NASDAQ:IMNM – Free Report) – Investment analysts at Wedbush increased their FY2024 earnings per share (EPS) estimates for Immunome in a report released on ...
Analysts Set Spruce Biosciences, Inc. (NASDAQ:SPRB) Target Price at $5.67
ETF DAILY NEWS· 7 days agoSpruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) has been assigned a consensus rating of “Hold” from the eight brokerages that are covering the firm, Marketbeat Ratings ...